Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Tranexamic Acid for Peptic Ulcer Bleeding
NCT05248321Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- Mar 2022
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of tranexamic acid in Peptic ulcer hemorrhage (PUB) (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Rate of the early treatment failure of the index ulcer at 4 days. Started Mar 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Peptic ulcer hemorrhage (PUB)
Beyond the preview
Go deeper on NCT05248321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05248321.